RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency - Wikidata - wikimedia - TriplyDB

RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency

RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency

http://www.wikidata.org/entity/Q36536499

about

Improved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickase Highly efficient biallelic genome editing of human ES/iPS cells using a CRISPR/Cas9 or TALEN system.Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy?Gene cassette knock-in in mammalian cells and zygotes by enhanced MMEJ Genome Editing with CRISPR-Cas9: Can It Get Any Better?Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells Identification and characterization of rabbit ROSA26 for gene knock-in and stable reporter gene expression.A CRISPR Path to Engineering New Genetic Mouse Models for Cardiovascular Research Ultra-superovulation for the CRISPR-Cas9-mediated production of gene-knockout, single-amino-acid-substituted, and floxed mice.CRISPR RNA-guided FokI nucleases repair a PAH variant in a phenylketonuria model.Efficient Generation of Orthologous Point Mutations in Pigs via CRISPR-assisted ssODN-mediated Homology-directed Repair.Promoting Cas9 degradation reduces mosaic mutations in non-human primate embryos Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage One-Step Biallelic and Scarless Correction of a β-Thalassemia Mutation in Patient-Specific iPSCs without Drug Selection.CRISPR/Cas9-Mediated Genome Editing Corrects Dystrophin Mutation in Skeletal Muscle Stem Cells in a Mouse Model of Muscle Dystrophy.Efficient generation of mice carrying homozygous double-floxp alleles using the Cas9-Avidin/Biotin-donor DNA system.Small molecules enhance CRISPR/Cas9-mediated homology-directed genome editing in primary cells.Small molecules and their role in effective preclinical target validation.CRISPR Editing in Biological and Biomedical Investigation.Developmental history and application of CRISPR in human disease.CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.Advances in the delivery of RNA therapeutics: from concept to clinical reality.Organoid technologies meet genome engineering.CRISPR/Cas9 for plant genome editing: accomplishments, problems and prospects.Use of genome-editing tools to treat sickle cell disease.Regulation of Single-Strand Annealing and its Role in Genome Maintenance.Clustered Regularly Interspaced Short Palindromic Repeats: Challenges in Treating Retinal Disease.CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes.Precision genome editing in the CRISPR era.The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups.Genome and Epigenome Editing in Mechanistic Studies of Human Aging and Aging-Related Disease.A Catalog of Regulatory Sequences for Trait Gene for the Genome Editing of Wheat.Production of immunodeficient rabbits by multiplex embryo transfer and multiplex gene targeting Rabbit models for biomedical research revisited via genome editing approaches.Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.CRISPR is knocking on barn door.Disruption of diphthamide synthesis genes and resulting toxin resistance as a robust technology for quantifying and optimizing CRISPR/Cas9-mediated gene editing.Assembly of CRISPR ribonucleoproteins with biotinylated oligonucleotides via an RNA aptamer for precise gene editing.CRISPR/Cas9 Genome-Editing System in Human Stem Cells: Current Status and Future Prospects.Scarless Genome Editing of Human Pluripotent Stem Cells via Transient Puromycin Selection.

P2860

Q29114083-EFA03E06-3399-4AAA-BD39-298449FBBAD1 Q33701667-12C70153-425B-465F-9AA1-4BB0E295387F Q33802540-BE429D68-0958-489E-96CD-27FACE8C1953 Q34546043-64B49AFB-D384-4DAD-BA9F-12A0018DA098 Q36025657-43230A09-BFD7-49FD-9842-39AF28A0227E Q36412556-4E9DE3A2-835F-4398-B1F3-38B791BAA77C Q36840970-68845096-177F-47CF-86E2-99FE3177D177 Q36940626-6B5848C8-A0DD-4BEC-9A95-9AFA74E9BEAE Q37216828-244A21A9-AAFF-4286-BA2D-0B83C0651CD3 Q37369090-B1890760-8C2A-4E68-9BDB-6B21D834EE7B Q37501565-B3FE15F4-F09A-47B1-AB59-92289DF0BCD3 Q37622753-E62C790C-C49F-49CC-B6D2-BAFB13B45839 Q37655265-E782C089-B188-4B55-9E6F-3C3170789054 Q37718157-960B138A-4B31-4971-9919-679DD90026C2 Q37718519-C115394C-3137-41E7-81E3-6A85C416483F Q37743468-64AA49EF-DB68-4945-8575-95A06AC20D5A Q38615359-53062EF3-A866-4EC9-BB19-B749E6EABF53 Q38638919-F86B6EE5-E8EF-4985-8E50-C767AB2314D0 Q38645581-9E56F591-EECC-4793-9924-CDCF8443317A Q38669948-DBF0B9DC-5D25-4473-8E94-E9D11100E0AF Q38680345-5166CE9B-8EB7-4578-9AAC-7EFB617921E7 Q38706445-9265EB5F-EF11-4E6A-B669-7B037C6DA0A6 Q38716335-BEE9AD34-EDFD-40E8-B758-715A9E77071C Q38817650-DF7A183C-38C3-4587-9396-2E42EF7F8513 Q38850483-302391FF-13CD-4458-B735-005275B69663 Q38906341-E4354028-61CD-4149-B1BB-789D390701A2 Q38917393-1574B548-2E35-46F6-8370-BD635241E5B1 Q39014648-9C6881B8-CBD7-47B9-A737-CA9B0EB74623 Q39126189-C752072B-5EA5-4B56-8C36-72D52DCF1B91 Q39260698-1001A55B-1CB8-4A38-AF3E-218514F6193C Q40424829-4DF87E96-F711-413B-B38F-421FF6191B46 Q41340942-E7C6BF85-7B64-4518-A44F-02721D7653F3 Q41831836-09691CCC-05AA-4DA9-9C83-DA3ABD59978A Q42668809-08D0E57A-466F-42FF-8A10-49154AD968B3 Q45875285-4847BB38-48F7-449B-89D3-E0ACA9704E9B Q46279732-20ACE43D-427A-431E-BB31-ECE5581CDFEC Q46440057-DEEACCAE-4322-492C-B186-1832B47F3CFB Q47106725-68DD107E-98D7-4701-8F2A-4A44F7EEE631 Q47161696-F43D6FAC-2FD8-43AC-9830-5EA391555B5E Q47196011-2F9C75D8-9EBF-4BC1-A89F-2C2216C9975C

P2860

RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency

http://www.wikidata.org/entity/Q36536499

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency

@ast

RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency

@en

type

label

RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency

@ast

RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency

@en

prefLabel

RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency

@ast

RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency

@en

P1433

Q36536499-D4D20EB0-50DE-47BB-8C34-B37B9C9444EE

P1476

Q36536499-4502B4A6-CF93-4421-A893-08AD926875DF

P2093

Q36536499-23E73506-D9CF-4F5B-81A2-2DAFB83EC038

Q36536499-4D82093D-4AB5-46D5-BE00-EA3507A1CE6F

Q36536499-516C03EB-0CB0-44B2-B1C6-25F2C357A45B

Q36536499-922D8294-E9D1-43BB-9CEC-5B676984F706

Q36536499-9464279D-23BD-44FD-84D4-DA68DC623019

Q36536499-F065BF87-C2C0-43D6-96A7-3FF375286933

P2860

Q36536499-10355663-97C8-48A3-A342-BF0BD3A0AF3E

Q36536499-15D6BC24-B3F9-4A81-950F-472BA17483C4

Q36536499-1ADD7862-861F-431F-A537-7901F2CFE9A4

Q36536499-542082BD-11A5-46AE-AE65-AA251BD80DCF

Q36536499-64B8303A-5100-4496-AB0F-E39604593654

Q36536499-6F449149-678C-4368-949B-CC6FADE33173

Q36536499-6F656662-F868-4D5E-8621-AE1BF3F4B10D

Q36536499-74F5B0C3-792C-436E-AF13-E83C2E721127

Q36536499-83BA8A88-E155-461D-B9DF-71E9672C0512

Q36536499-89570CF1-3286-4723-B580-8895021852D0

P2888

Q36536499-253DC551-4265-44E8-B743-F24DB42347E6

P304

Q36536499-0FC89203-8A2B-4620-AD6E-6881BC57FAAC

P31

Q36536499-E8141EBB-F0B2-4653-A8E6-3C87387A17F0

P356

Q36536499-C2BD4E84-692C-4E78-B224-E8B9701936BC

P407

Q36536499-CBD215DE-14D1-47DE-BA6A-6334B081E197

P478

Q36536499-C5092B80-26B1-4D25-803B-346A7E893253

P577

Q36536499-8BF05676-9710-45EA-A199-3F86EA4F4669

P5875

Q36536499-6EE6BF7C-7479-40F9-8F14-035DEADBB573

P698

Q36536499-5970DC7A-6BF4-4A08-9ACD-04E132C6BEBA

P921

Q36536499-AB3A08D2-BDFF-4EA0-9753-F64FA88FBF78

P932

Q36536499-8B96ED15-530E-4435-8833-99DEB5BA3FD7

P356

P1433

Nature Communications

P1476

RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency

@en

P2093

Dongshan Yang

http://www.w3.org/2001/XMLSchema#string

Jie Xu

http://www.w3.org/2001/XMLSchema#string

Jifeng Zhang

http://www.w3.org/2001/XMLSchema#string

Jun Song

http://www.w3.org/2001/XMLSchema#string

Tianqing Zhu

http://www.w3.org/2001/XMLSchema#string

Y Eugene Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Genome engineering using the CRISPR-Cas9 system

Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2.

Efficient genome editing in zebrafish using a CRISPR-Cas system

Therapeutic genome editing: prospects and challenges

The consequences of Rad51 overexpression for normal and tumor cells

Targeted integration in rat and mouse embryos with zinc-finger nucleases

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering

DNA targeting specificity of RNA-guided Cas9 nucleases

Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting

A chemical compound that stimulates the human homologous recombination protein RAD51

P2888

P304

10548

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS10548

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292208084

http://www.w3.org/2001/XMLSchema#string

P698

26817820

http://www.w3.org/2001/XMLSchema#string

P921

P932

4738357

http://www.w3.org/2001/XMLSchema#string